Clinical Trials Directory

Trials / Conditions / Guillain-Barre Syndrome

Guillain-Barre Syndrome

46 registered clinical trials studyying Guillain-Barre Syndrome6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingComparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Sy
NCT05114941
The First Affiliated Hospital of Zhengzhou UniversityN/A
RecruitingAn Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Gui
NCT07020819
Annexon, Inc.Phase 3
Not Yet RecruitingNoninvasive Support for Acute Respiratory Failure in Guillain-Barré Syndrome
NCT06996509
Assiut UniversityN/A
RecruitingEarly vs. Late Tracheostomy in Patients With Guillain -Barre Syndrome
NCT06612242
Meir Medical Center
WithdrawnEvaluating Efgartigimod in Patients With Guillain-Barré Syndrome
NCT05701189
Chafic KaramPhase 2
RecruitingBiomarkers in Autoimmune Disease of Nervous System
NCT06502015
Tongji Hospital
UnknownPrognostic Indicators of Gullian-Barre Syndrome
NCT06300359
Assiut University
CompletedVentilator Weaning Practices in Patients Intubated for Guillain-Barré Syndrome or Myasthenia Gravis
NCT07022028
Poitiers University Hospital
UnknownPredictive Value of Neuromuscular Ultrasound of Cranial Nerves in Guillain-Barré Syndrome
NCT06200454
Assiut University
CompletedArtificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology
NCT06334796
Fundación para la Lucha contra las Enfermedades Neurológicas de la InfanciaEARLY_Phase 1
UnknownRWE-based Treatment Patterns and Outcomes in CIDP
NCT05940922
RwHealth
CompletedExploring Accessible Beauty for Individuals With Upper Extremity Deficits
NCT05945784
Casa Colina Hospital and Centers for Healthcare
RecruitingVentilator Trigger Sensitivity Adjustment Versus Threshold Inspiratory Muscle Training on Arterial Blood Gases
NCT06167239
Cairo UniversityN/A
WithdrawnExpression Profile of ERK5 and PKM2 Kinases in Neuroinflammatory Diseases.
NCT04674163
Centre Hospitalier Régional d'OrléansN/A
UnknownGene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Cov
NCT05630313
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
UnknownUltrasonography and Electrophysiology in GBS
NCT05284786
Assiut University
CompletedEffects of Proprioceptive Neuromuscular Training on Sensory and Motor Function in Guillain Barre Syndrome
NCT05491096
Riphah International UniversityN/A
CompletedDiaphragm Thickness by Ultrasonography in Neurological Disorders
NCT05324176
Mansoura UniversityN/A
UnknownMini-pool Intravenous Immunoglobulin (MP-IVIG) in Guillain-Barré Syndrome
NCT04550611
Assiut UniversityN/A
CompletedIVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients
NCT05104762
Assiut UniversityPhase 2 / Phase 3
CompletedAn Assistive Powered Wheelchair: Stage 2 Trial
NCT05292690
East Kent Hospitals University NHS Foundation Trust
CompletedA Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome
NCT04752566
Alexion Pharmaceuticals, Inc.Phase 3
CompletedEfficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome
NCT04701164
Annexon, Inc.Phase 3
CompletedPredictors and Prognostic Factors of Gullian Barrie Syndrome Outcome
NCT04927598
Assiut University
UnknownEfficacy of Intravenous Gamma Globulin on Guillain-Barre Syndrome
NCT04303962
Ning Wang, MD., PhD.
UnknownBiomarkers in Polyradiculoneuropathies
NCT04249752
University Hospital, Montpellier
UnknownNeuromuscular Ultrasound in Correlation to Neurophysiological Findings
NCT04092140
Assiut University
TerminatedPeripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome
NCT04053452
Duke UniversityN/A
UnknownEarly Prediction of Respiratory and Autonomic Complications of GBS Using Neuromuscular Ultrasound
NCT04166357
Mansoura University Hospital
CompletedNeurology Inpatient Clinical Education Trial
NCT03826056
Dartmouth-Hitchcock Medical CenterN/A
WithdrawnFeasibility of Two New Software Modules for the Rehabilitation of Patients With Neuromuscular Upper Limb Impai
NCT03268304
Reha Rheinfelden
UnknownChanges in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation
NCT03801135
University Medical Centre LjubljanaN/A
CompletedNeurologic Manifestations of the Arbovirus Infection in Colombia
NCT03206541
Johns Hopkins University
UnknownsCD163 as a Potential Biomarker in Guillain- Barré Syndrome
NCT02582853
University of Aarhus
WithdrawnGastrointestinal Transit Time in Patients With Guillain-Barré Syndrome
NCT02459808
University of Aarhus
UnknownPatientSpot Formerly Known as ArthritisPower
NCT03840928
Global Healthy Living Foundation
UnknownEarly and Late Prognosis in Patients With Guillain-Barre Syndrome
NCT06041451
First Affiliated Hospital of Wenzhou Medical UniversityPhase 4
UnknownPrognosis in Patients With Guillain-Barre Syndrome
NCT06032741
First Affiliated Hospital of Wenzhou Medical University
UnknownChange of Nerve Conduction Properties in IVIg Dependent Neuropathies
NCT01655394
University of Cologne
CompletedRegional Citrate Anticoagulation in Plasma Exchange Treatment
NCT01370200
University Medical Centre LjubljanaN/A
CompletedBrain Computer Interface for Communication in ICU: a Feasibility Study
NCT01005524
University of Versailles
CompletedIntravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Synd
NCT01306578
Mansoura University Children HospitalN/A
CompletedSafety Study of GBS Following Menactra Meningococcal Vaccination
NCT00575653
Harvard Pilgrim Health Care
CompletedAssessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine
NCT00056810
FDA Office of Orphan Products DevelopmentPhase 2
TerminatedRandomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
NCT00004833
Emory UniversityN/A
CompletedSpontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
NCT03941184
Mayo Clinic